Schedule 13G ownership disclosure
Inmune Bio Inc
Security class unavailable · CUSIP: 45782T105
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,454,400
- Percent of class
- 6.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-24-005996
- Form type
- SC 13G
- Filer
- HIGHBRIDGE CAPITAL MANAGEMENT LLC
- CIK
- CIK 919185
- Filed
- Oct 25, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership